Full-Time

Vice President/Senior Vice President

Clinical Development, Oncology

Confirmed live in the last 24 hours

Coherus BioSciences

Coherus BioSciences

201-500 employees

Develops and commercializes biosimilars for healthcare

Biotechnology
Healthcare

Compensation Overview

$275k - $375kAnnually

Senior

San Carlos, CA, USA

Category
Physicians & Surgeons
Medical, Clinical & Veterinary
Required Skills
Google Cloud Platform
Requirements
  • M.D. required with 7+ years of experience in a clinical research role in the biopharmaceutical industry, with significant role in a leadership capacity.
  • Board certified Oncologist with oncology clinical experience and drug development experience
  • Experience directly managing clinical research staff and will have proven track record in late-stage development and regulatory filing.
  • Experience with leading early and late-stage clinical trials, regulatory filings, and product launches.
  • Ability to work effectively across functions, particularly when interfacing with clinical operations, statisticians, pharmacovigilance, and regulatory affairs.
  • Executive leadership skills to educate and influence stakeholders and to add value to strategic business planning and decision-making.
  • Exceptional interpersonal, problem-solving and written and verbal communication skills.
  • Excellent organizational and project management skills.
  • Excellent writing, organizational, and communication skills
  • Outstanding clinical and business judgment required
  • Experience with GCP/ICH/FDA requirements, clinical trial design and strategies, commercial and publication strategy and medical information process
  • Experienced in presenting to board members, investors, potential partners, and company staff
  • Proven ability to work in a cross-functional and collaborative environment
  • Willingness and availability to travel
  • Prior experience working in a small/emerging company is strongly preferred
  • Ability to provide scientific and clinical expertise to a clinical development program and clinical strategies for a product to obtain regulatory approval
  • Demonstrated ability to establish relationships with internal colleagues and external collaborators (e.g., investigators, KOL's/CROs) and represent the company in public (e.g., scientific conferences, partners)
  • Demonstrated ability in decision-making, influencing, leadership, and affecting change by using a collaborative approach
  • Excellent knowledge of relevant FDA regulations and guidelines for conducting clinical trials
  • Must be science-and data-driven
  • Must have a results-oriented work ethic and a positive, can-do attitude
  • Must be willing and able to be 'hands on' and willing to 'roll-up sleeves' and delve into details
  • Strong business acumen
  • Highly intelligent and detail-oriented with an ability to think strategically and operationally on a wide range of issues in a solutions-oriented manner.
  • Experience with providing mentorship to direct reports and maintaining clear communication on performance to direct reports (preferred but not required)
Responsibilities
  • Continuing the clinical development activities of our oncology products
  • Provide strategic leadership and design input for all Oncology clinical programs
  • Write / review medical aspects of core study and regulatory documents including clinical research plans, protocols, investigator brochures, clinical study reports and regulatory submissions.
  • Oversee medical monitoring support to clinical investigators and internal/external team members (e.g., address medical and eligibility questions related to clinical protocols, answer product candidate related questions)
  • Oversee safety for clinical studies (e.g., SAE reporting, ongoing review of events, integrated evaluation)
  • Review and interpret clinical trial data
  • Contribute to the development and review of scientific publications
  • Represent clinical research on internal program teams and external project teams
  • Participate in discussions with regulatory authorities as appropriate
  • Support Business Development activities as needed

Coherus BioSciences develops and sells biosimilars, which are highly similar versions of approved biologic medicines used to treat various diseases. These biosimilars are designed to be as effective and safe as the original products but are offered at a lower cost, making them more affordable for patients and healthcare systems. The company focuses on research, development, and commercialization of these products, ensuring they meet strict regulatory standards for quality and efficacy. Coherus aims to improve patient lives by expanding access to essential biologic treatments, helping to offset rising healthcare costs. Their business model allows them to generate revenue through the sale of these cost-effective alternatives, giving them a competitive advantage in the biopharmaceutical market.

Company Stage

IPO

Total Funding

$114.5M

Headquarters

Redwood City, California

Founded

2010

Growth & Insights
Headcount

6 month growth

-6%

1 year growth

-13%

2 year growth

-20%
Simplify Jobs

Simplify's Take

What believers are saying

  • The launch of innovative products like the Udenyca wearable injector device demonstrates Coherus' commitment to improving patient care and expanding market share.
  • The divestiture of non-core assets like the Lucentis biosimilar allows Coherus to focus resources on its core oncology franchise, potentially driving higher growth and profitability.
  • Strategic board appointments and clinical collaborations position Coherus for sustained innovation and leadership in the biosimilar market.

What critics are saying

  • The competitive landscape for biosimilars is intense, requiring continuous innovation and cost management to maintain market position.
  • Frequent restructuring and staff reductions, as seen with the recent 30% cut, could impact employee morale and operational efficiency.

What makes Coherus BioSciences unique

  • Coherus BioSciences focuses exclusively on biosimilars, providing cost-effective alternatives to expensive biologic medicines, unlike competitors who may offer a broader range of pharmaceuticals.
  • Their rigorous approval process ensures high standards of quality and efficacy, setting them apart in a market where regulatory compliance is critical.
  • Strategic collaborations, such as with the Cancer Research Institute, enhance their research capabilities and expand their treatment options.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Competitive base salary

Target bonus based on performance

stock options

Medical, dental, & vision coverage

PTO

401(k) plan

FSA